Telegraph investigation finds ‘critical’ information missing from early warnings about AstraZeneca vaccine’s side effects ...

AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the "they won’t" camp ...

The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool ...

I would have thought, given the UK has a very poor manufacturing base for vaccines, and AstraZeneca was willing ... part of a much bigger investment the benefits are huge to the taxpayer.

AstraZeneca have not stated plans for an alternative. An FT report meanwhile said that vaccines were “off strategy” for AstraZeneca, suggesting “figures on both sides of the negotiations hav ...

LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England ...

AstraZeneca has cancelled a planned £450 million investment in a vaccine manufacturing plant in Merseyside, saying Labour failed to match the previous government’s offer of support. The ...

LONDON (AP) — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new ...

AstraZeneca canceled its £450 million vaccine manufacturing plant in Liverpool after rejecting a £78 million government funding offer. The company raised concerns over NHS drug pricing policies ...

The Financial Times leads with the news that pharmaceutical giant AstraZeneca has cancelled ... was going to "make the next generation of flu vaccines and help UK resilience against future pandemics".